Impact of supply chain disruptions and drug shortages on drug utilization: A scoping review protocol

• Published in: PloS one 2024-11, Vol.19 (11), p.e0313298
• Main Authors: Santhireswaran, Araniy, Ho, Martin, Fuller, Kaitlin, Gaudette, Etienne, Burry, Lisa, Tadrous, Mina
• Format: Article
• Language: English
• Subjects: Analysis; Case reports; Dexmedetomidine; Disruption; Drug use; Drug Utilization - statistics & numerical data; Drugs; Grey literature; Humans; Interdisciplinary aspects; Literature reviews; Logistics; Management; Medicine and Health Sciences; Observational studies; Pharmaceutical industry; Pharmaceutical Preparations - supply & distribution; Pharmaceuticals; Population studies; Prescribing; Prescription drugs; Prescription Drugs - supply & distribution; R&D; Research & development; Research and Analysis Methods; Review Literature as Topic; Search engines; Search methods; Search strategies; Shortages; Social Sciences; Study Protocol; Subject heading schemes; Supply and demand; Supply chains; Trends; Utilization; Vaccines; Valsartan
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0313298

This proposed scoping review aims to examine studies assessing the impact of drug shortages on population-level drug utilization trends. The objectives of this review are to a) assess which drugs have been studied and describe associated drug characteristics, b) determine jurisdictions and healthcare settings that have conducted these studies, and c) describe how changes in drug use and the extent of shortage impacts are reported in literature. Drug shortages continue to impair drug access and delivery of quality care across the world. However, the impact of drug supply disruptions on availability and drug use are understudied in current literature. This proposed scoping review will identify this gap and inform future research initiatives aimed at determining the real-world impacts of drug shortages. Published and unpublished observational studies reporting on the effects of drug supply chain disruptions (shortages, discontinuations, and safety-based withdrawals) on consequent utilization trends faced by pharmaceutical products (i.e. prescription drugs, over-the-counter drugs, vaccines, therapy products, pharmaceutical solutions). Literature reviews, meta-analyses, randomized control trials, case series, case reports, and opinion pieces will be excluded. The search strategy will combine two key search concepts: drug shortages and drug utilization. The search will be conducted in MEDLINE and EMBASE. This will be followed by an extensive grey literature search in grey literature databases, targeted websites and Google. Furthermore, reference lists of included articles will be searched. Articles will be independently screened, selected and extracted by two reviewers. Data will be descriptively analyzed and presented in tables. Review registration number: Open Science Framework, https://osf.io/2p6e5.